Open science versus commercialization: an Open Debate in Genome Medicine
In the first Open Debate published in Genome Medicine, Timothy Caulfield and colleagues investigate the potential conflict between open science and commercialization policies in genomics research. Tackling an issue that’s fraught with controversy, the authors discuss the inconsistencies in messages aimed towards promoting openness or commercialization of science, and offer a solution for integrating both… Read more »